{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:48:39Z","timestamp":1777650519676,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The peritoneal cavity is the second commonest site of mesothelioma after the pleural cavity. There are five histological types of peritoneal mesothelioma with variable symptomatology, clinical presentation and prognosis. Cystic mesothelioma is a borderline malignant neoplasm with a favourable prognosis, well-differentiated papillary mesothelioma is generally a low-grade malignancy, and all other varieties such as epithelioid, sarcomatoid and biphasic mesothelioma are highly malignant types of peritoneal mesothelioma with poor prognosis. Malignant peritoneal mesothelioma was considered inevitably fatal prior to the introduction of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in selected cases where long-term survival and cure could be achieved. However, the survival benefits following CRS and HIPEC mainly depend on completeness of cytoreduction, which come at the cost of high morbidity and potential mortality. Using the acronym \u2018PAUSE\u2019, we aimed at describing the key imaging findings that impact surgical decision-making in patients with peritoneal mesothelioma. PAUSE stands for peritoneal cancer index, ascites and abdominal wall disease, unfavourable sites of involvement, small bowel and mesenteric disease and extraperitoneal disease. Reporting components of \u2018PAUSE\u2019 is crucial for patient selection. Despite limitations of CT in accurately depicting the volume of disease, describing findings in terms of PAUSE plays an important role in excluding patients who might not benefit from CRS and HIPEC.<\/jats:p>","DOI":"10.1186\/s13244-021-01118-y","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T12:03:17Z","timestamp":1637755397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Communicating imaging findings in peritoneal mesothelioma: the impact of \u2018PAUSE\u2019 on surgical decision-making"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-375X","authenticated-orcid":false,"given":"Anuradha","family":"Chandramohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Thrower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman John","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohin","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18:985\u2013990. https:\/\/doi.org\/10.1093\/annonc\/mdl345","journal-title":"Ann Oncol"},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canep.2017.10.008","volume":"51","author":"SA Salo","year":"2017","unstructured":"Salo SA, Ilonen I, Laaksonen S, Myll\u00e4rniemi M, Salo JA, Rantanen T (2017) Epidemiology of malignant peritoneal mesothelioma: a population-based study. Cancer Epidemiol 51:81\u201386. https:\/\/doi.org\/10.1016\/j.canep.2017.10.008","journal-title":"Cancer Epidemiol"},{"key":"1118_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","volume":"1","author":"KH Antman","year":"1983","unstructured":"Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS (1983) Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol 1:386\u2013391. https:\/\/doi.org\/10.1200\/JCO.1983.1.6.386","journal-title":"J Clin Oncol"},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","volume":"13","author":"C Brigand","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F et al (2006) Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13:405\u2013412. https:\/\/doi.org\/10.1245\/ASO.2006.05.041","journal-title":"Ann Surg Oncol"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/oem.51.12.804","volume":"51","author":"R Spirtas","year":"1994","unstructured":"Spirtas R, Heineman EF, Bernstein L et al (1994) Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 51:804\u2013811. https:\/\/doi.org\/10.1136\/oem.51.12.804","journal-title":"Occup Environ Med"},{"key":"1118_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/01913120252959227","volume":"26","author":"VL Roggli","year":"2002","unstructured":"Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002) Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol 26:55\u201365. https:\/\/doi.org\/10.1080\/01913120252959227","journal-title":"Ultrastruct Pathol"},{"key":"1118_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/oem.2006.030155","volume":"64","author":"AR Gibbs","year":"2007","unstructured":"Gibbs AR (2007) Tumours of the serosal membranes. Armed forces institute of pathology atlas of tumour pathology, fourth series, fascicle 3. Occup Environ Med 64:288. https:\/\/doi.org\/10.1136\/oem.2006.030155","journal-title":"Occup Environ Med"},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","volume":"34","author":"Y Sekido","year":"2013","unstructured":"Sekido Y (2013) Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 34:1413\u20131419. https:\/\/doi.org\/10.1093\/carcin\/bgt166","journal-title":"Carcinogenesis"},{"key":"1118_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3816\/CLC.2003.n.031","volume":"5","author":"AF Gazdar","year":"2003","unstructured":"Gazdar AF, Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5:177\u2013181. https:\/\/doi.org\/10.3816\/CLC.2003.n.031","journal-title":"Clin Lung Cancer"},{"issue":"5","key":"1118_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","volume":"8","author":"A Garc\u00eda-Fadrique","year":"2017","unstructured":"Garc\u00eda-Fadrique A, Mehta A, Mohamed F, Dayal S, Cecil T, Moran BJ (2017) Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review. J Gastrointest Oncol 8(5):915\u2013924. https:\/\/doi.org\/10.21037\/jgo.2017.08.01","journal-title":"J Gastrointest Oncol"},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge D, Zenati MS, Austin F et al (2014) Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol 21:1159\u20131165. https:\/\/doi.org\/10.1245\/s10434-013-3358-y","journal-title":"Ann Surg Oncol"},{"key":"1118_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/030089160308900307","volume":"89","author":"YIZ Acherman","year":"2003","unstructured":"Acherman YIZ, Welch LS, Bromley CM, Sugarbaker PH (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89:269\u2013273","journal-title":"Tumori"},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG et al (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142:89\u2013108. https:\/\/doi.org\/10.5858\/arpa.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","volume":"28","author":"M Cigognetti","year":"2015","unstructured":"Cigognetti M, Lonardi S, Fisogni S et al (2015) BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol 28:1043\u20131057. https:\/\/doi.org\/10.1038\/modpathol.2015.65","journal-title":"Mod Pathol"},{"key":"1118_CR15","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","volume":"6","author":"A Cristaudo","year":"2011","unstructured":"Cristaudo A, Bonotti A, Simonini S et al (2011) Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol 6:1587\u20131593. https:\/\/doi.org\/10.1097\/JTO.0b013e31821e1c08","journal-title":"J Thorac Oncol"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","volume":"12","author":"R Hassan","year":"2006","unstructured":"Hassan R, Remaley AT, Sampson ML et al (2006) Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 12:447\u2013453. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1477","journal-title":"Clin Cancer Res"},{"key":"1118_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1245\/s10434-006-9192-8","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Martinetti A et al (2007) Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 14:500\u2013508. https:\/\/doi.org\/10.1245\/s10434-006-9192-8","journal-title":"Ann Surg Oncol"},{"key":"1118_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00000478-198810000-00001","volume":"12","author":"SW Weiss","year":"1988","unstructured":"Weiss SW, Tavassoli FA (1988) Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 12:737\u2013746","journal-title":"Am J Surg Pathol"},{"key":"1118_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jviscsurg.2013.12.014","volume":"151","author":"I Jouvin","year":"2014","unstructured":"Jouvin I, Dohan A, Gergi P, Pocard M (2014) Intra-abdominal benign multicystic peritoneal mesothelioma. J Visc Surg 151:155\u2013157. https:\/\/doi.org\/10.1016\/j.jviscsurg.2013.12.014","journal-title":"J Visc Surg"},{"key":"1118_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00464-001-0052-0","volume":"16","author":"C Vara-Thorbeck","year":"2002","unstructured":"Vara-Thorbeck C, Toscano-Mendez R (2002) Peritoneal cystic mesothelioma. Surg Endosc 16:220. https:\/\/doi.org\/10.1007\/s00464-001-0052-0","journal-title":"Surg Endosc"},{"key":"1118_CR21","doi-asserted-by":"publisher","first-page":"20170361","DOI":"10.1259\/bjr.20170361","volume":"90","author":"A Chandramohan","year":"2017","unstructured":"Chandramohan A, Thrower A, Shah N, Mohamed F (2017) Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre. Br J Radiol 90:20170361","journal-title":"Br J Radiol"},{"key":"1118_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1148\/rg.241035068","volume":"24","author":"WL Wong","year":"2004","unstructured":"Wong WL, Johns TA, Herlihy WG, Martin HL (2004) Best cases from the AFIP: multicystic mesothelioma. Radiographics 24:247\u2013250. https:\/\/doi.org\/10.1148\/rg.241035068","journal-title":"Radiographics"},{"key":"1118_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/OGX.0b013e31819f93d4","volume":"64","author":"AM Vallerie","year":"2009","unstructured":"Vallerie AM, Lerner JP, Wright JD, Baxi LV (2009) Peritoneal inclusion cysts: a review. Obstet Gynecol Surv 64:321\u2013334. https:\/\/doi.org\/10.1097\/OGX.0b013e31819f93d4","journal-title":"Obstet Gynecol Surv"},{"key":"1118_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s0009-9260(05)80113-8","volume":"48","author":"AK Hasan","year":"1993","unstructured":"Hasan AK, Sinclair DJ (1993) Case report: calcification in benign cystic peritoneal mesothelioma. Clin Radiol 48:66\u201367. https:\/\/doi.org\/10.1016\/s0009-9260(05)80113-8","journal-title":"Clin Radiol"},{"key":"1118_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::aid-cncr2820650218>3.0.co;2-w","volume":"65","author":"D Daya","year":"1990","unstructured":"Daya D, McCaughey WT (1990) Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 65:292\u2013296. https:\/\/doi.org\/10.1002\/1097-0142(19900115)65:2%3c292::aid-cncr2820650218%3e3.0.co;2-w","journal-title":"Cancer"},{"key":"1118_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0959-8049(95)00574-9","volume":"32A","author":"K Hoekman","year":"1996","unstructured":"Hoekman K, Tognon G, Risse EK, Bloemsma CA, Vermorken JB (1996) Well-differentiated papillary mesothelioma of the peritoneum: a separate entity. Eur J Cancer 32A:255\u2013258. https:\/\/doi.org\/10.1016\/0959-8049(95)00574-9","journal-title":"Eur J Cancer"},{"issue":"1","key":"1118_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ygyno.2005.03.031","volume":"98","author":"AV Hoekstra","year":"2005","unstructured":"Hoekstra AV, Riben MW, Frumovitz M, Liu J, Ramirez PT (2005) Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol 98(1):161\u2013167. https:\/\/doi.org\/10.1016\/j.ygyno.2005.03.031","journal-title":"Gynecol Oncol"},{"key":"1118_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2214\/ajr.155.6.2122674","volume":"155","author":"FA Lovell","year":"1990","unstructured":"Lovell FA, Cranston PE (1990) Well-differentiated papillary mesothelioma of the peritoneum. AJR Am J Roentgenol 155:1245\u20131246. https:\/\/doi.org\/10.2214\/ajr.155.6.2122674","journal-title":"AJR Am J Roentgenol"},{"key":"1118_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/sonc.2002.30236","volume":"29","author":"PH Sugarbaker","year":"2002","unstructured":"Sugarbaker PH, Acherman YIZ, Gonzalez-Moreno S et al (2002) Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol 29:51\u201361. https:\/\/doi.org\/10.1053\/sonc.2002.30236","journal-title":"Semin Oncol"},{"issue":"605\u2013621","key":"1118_CR30","doi-asserted-by":"publisher","first-page":"xi","DOI":"10.1016\/s1055-3207(03)00045-0","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, Glehen O (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12(605\u2013621):xi. https:\/\/doi.org\/10.1016\/s1055-3207(03)00045-0","journal-title":"Surg Oncol Clin N Am"},{"key":"1118_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jso.10081","volume":"79","author":"S Gonz\u00e1lez-Moreno","year":"2002","unstructured":"Gonz\u00e1lez-Moreno S, Yan H, Alcorn KW, Sugarbaker PH (2002) Malignant transformation of \u201cbenign\u201d cystic mesothelioma of the peritoneum. J Surg Oncol 79:243\u2013251. https:\/\/doi.org\/10.1002\/jso.10081","journal-title":"J Surg Oncol"},{"key":"1118_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1053\/hupa.2003.31","volume":"34","author":"RN Sawh","year":"2003","unstructured":"Sawh RN, Malpica A, Deavers MT et al (2003) Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol 34:369\u2013374. https:\/\/doi.org\/10.1053\/hupa.2003.31","journal-title":"Hum Pathol"},{"key":"1118_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.ejso.2010.08.130","volume":"36","author":"D Baratti","year":"2010","unstructured":"Baratti D, Vaira M, Kusamura S et al (2010) Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 36:1047\u20131053. https:\/\/doi.org\/10.1016\/j.ejso.2010.08.130","journal-title":"Eur J Surg Oncol"},{"key":"1118_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncponc1039","volume":"5","author":"DA Fennell","year":"2008","unstructured":"Fennell DA, Gaudino G, O\u2019Byrne KJ, Mutti L, van Meerbeeck J (2008) Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol 5:136\u2013147. https:\/\/doi.org\/10.1038\/ncponc1039","journal-title":"Nat Clin Pract Oncol"},{"key":"1118_CR35","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644. https:\/\/doi.org\/10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"key":"1118_CR36","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, J\u00e4nne PA et al (2008) Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol 26:3567\u20133572. https:\/\/doi.org\/10.1200\/JCO.2007.15.2868","journal-title":"J Clin Oncol"},{"key":"1118_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander","year":"2013","unstructured":"Alexander HR, Bartlett DL, Pingpank JF et al (2013) Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 153:779\u2013786. https:\/\/doi.org\/10.1016\/j.surg.2013.01.001","journal-title":"Surgery"},{"key":"1118_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH (2007) Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2013a prospective study of 70 consecutive cases. Ann Surg Oncol 14:515\u2013525. https:\/\/doi.org\/10.1245\/s10434-006-9187-5","journal-title":"Ann Surg Oncol"},{"key":"1118_CR39","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jso.21787","volume":"103","author":"D Baratti","year":"2011","unstructured":"Baratti D, Kusamura S, Deraco M (2011) Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research. J Surg Oncol 103:822\u2013831. https:\/\/doi.org\/10.1002\/jso.21787","journal-title":"J Surg Oncol"},{"key":"1118_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00423-014-1253-z","volume":"400","author":"M Desantis","year":"2015","unstructured":"Desantis M, Bernard J-L, Casanova V et al (2015) Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 400:37\u201348. https:\/\/doi.org\/10.1007\/s00423-014-1253-z","journal-title":"Langenbecks Arch Surg"},{"key":"1118_CR41","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA et al (2015) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 22:1686\u20131693. https:\/\/doi.org\/10.1245\/s10434-014-3978-x","journal-title":"Ann Surg Oncol"},{"key":"1118_CR42","first-page":"9","volume":"69","author":"M Robella","year":"2014","unstructured":"Robella M, Vaira M, Mellano A et al (2014) Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC. Minerva Chir 69:9\u201315","journal-title":"Minerva Chir"},{"key":"1118_CR43","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1200\/JOP.2016.011908","volume":"12","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Turaga KK, Alexander HR, Deraco M, Hesdorffer M (2016) Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy. J Oncol Pract 12:928\u2013935. https:\/\/doi.org\/10.1200\/JOP.2016.011908","journal-title":"J Oncol Pract"},{"key":"1118_CR44","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.crad.2017.07.005","volume":"72","author":"A Chandramohan","year":"2017","unstructured":"Chandramohan A, Thrower A, Smith SA, Shah N, Moran B (2017) \u201cPAUSE\u201d: a method for communicating radiological extent of peritoneal malignancy. Clin Radiol 72:972\u2013980. https:\/\/doi.org\/10.1016\/j.crad.2017.07.005","journal-title":"Clin Radiol"},{"key":"1118_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"key":"1118_CR46","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan TD, Deraco M, Elias D et al (2011) A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer 117:1855\u20131863. https:\/\/doi.org\/10.1002\/cncr.25640","journal-title":"Cancer"},{"key":"1118_CR47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","volume":"22","author":"RN Low","year":"2015","unstructured":"Low RN, Barone RM, Lucero J (2015) Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708\u20131715. https:\/\/doi.org\/10.1245\/s10434-014-4041-7","journal-title":"Ann Surg Oncol"},{"key":"1118_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"J-L Koh","year":"2009","unstructured":"Koh J-L, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327\u2013333. https:\/\/doi.org\/10.1245\/s10434-008-0234-2","journal-title":"Ann Surg Oncol"},{"key":"1118_CR49","doi-asserted-by":"publisher","first-page":"13257","DOI":"10.1038\/s41598-020-70044-8","volume":"10","author":"SAS Salo","year":"2020","unstructured":"Salo SAS, Lantto E, Robinson E et al (2020) Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study. Sci Rep 10:13257. https:\/\/doi.org\/10.1038\/s41598-020-70044-8","journal-title":"Sci Rep"},{"key":"1118_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MNM.0000000000000649","volume":"38","author":"J Dubreuil","year":"2017","unstructured":"Dubreuil J, Giammarile F, Rousset P et al (2017) The role of 18F-FDG-PET\/ceCT in peritoneal mesothelioma. Nucl Med Commun 38:312\u2013318. https:\/\/doi.org\/10.1097\/MNM.0000000000000649","journal-title":"Nucl Med Commun"},{"issue":"2","key":"1118_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00261-019-02268-w","volume":"45","author":"FMK Elekonawo","year":"2019","unstructured":"Elekonawo FMK, Starremans B, Laurens ST et al (2019) Can [18F]F-FDG PET\/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer? Abdom Radiol (NY) 45(2):301\u2013306. https:\/\/doi.org\/10.1007\/s00261-019-02268-w","journal-title":"Abdom Radiol (NY)"},{"key":"1118_CR52","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1148\/rg.2020190170","volume":"40","author":"DH Ballard","year":"2020","unstructured":"Ballard DH, Mazaheri P, Oppenheimer DC et al (2020) Imaging of abdominal wall masses, masslike lesions, and diffuse processes. Radiographics 40:684\u2013706. https:\/\/doi.org\/10.1148\/rg.2020190170","journal-title":"Radiographics"},{"key":"1118_CR53","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2018.10.07","author":"LJ Spera","year":"2018","unstructured":"Spera LJ, Danforth RM, Hadad I (2018) Incisions and reconstruction approaches for large sarcomas. Transl Gastroenterol Hepatol. https:\/\/doi.org\/10.21037\/tgh.2018.10.07","journal-title":"Transl Gastroenterol Hepatol"},{"key":"1118_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","volume":"4","author":"SL Sangisetty","year":"2012","unstructured":"Sangisetty SL, Miner TJ (2012) Malignant ascites: A Review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 4:87\u201395. https:\/\/doi.org\/10.4240\/wjgs.v4.i4.87","journal-title":"World J Gastrointest Surg"},{"key":"1118_CR55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/bjs5.50256","volume":"4","author":"A Brandl","year":"2020","unstructured":"Brandl A, Westbrook S, Nunn S et al (2020) Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting. BJS Open 4:260\u2013267. https:\/\/doi.org\/10.1002\/bjs5.50256","journal-title":"BJS Open"},{"key":"1118_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cncr.20836","volume":"103","author":"TD Yan","year":"2005","unstructured":"Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839\u2013849. https:\/\/doi.org\/10.1002\/cncr.20836","journal-title":"Cancer"},{"key":"1118_CR57","volume-title":"A practical guide to peritoneal malignancy","author":"A Chandramohan","year":"2019","unstructured":"Chandramohan A, Thrower A (2019) Imaging in peritoneal malignancy. In: Cecil T, Bunni J, Mehta A (eds) A practical guide to peritoneal malignancy. CRC Press, Boca Raton"},{"key":"1118_CR58","doi-asserted-by":"publisher","first-page":"20170814","DOI":"10.1259\/bjr.20170814","volume":"91","author":"HS Elliott","year":"2018","unstructured":"Elliott HS, Metser U, de Perrot M et al (2018) 18F-FDG PET\/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center. Br J Radiol 91:20170814. https:\/\/doi.org\/10.1259\/bjr.20170814","journal-title":"Br J Radiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-021-01118-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-021-01118-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-021-01118-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T12:03:39Z","timestamp":1637755419000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-021-01118-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1186\/s13244-021-01118-y","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial or proprietary interests in any material discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}